Liver Diseases (2 Vols.)

Volume 1: Liver Diseases: Pathways, Mediators and Regulation; * Section I: Liver Diseases: Mediators and Regulation; Ubiquitin - Proteasome Pathway in the Pathogenesis of Liver Disease: Samuel W. French and Fawzia Bardag-Gorce; Collagen Gene Regulation in the Hepatic Stellate Cell: Branko Stefanovic and Richard A. Rippe; CYP2F1-Biochemical and Toxicological Aspects and Role in Alcohol-induced Liver Injury: Arthur I. Cederbaum; Alcohol and Methyl Transfer: Implications for Alcohol-Related Hepatocarcinogenesis: Felix Stickel et al.; Menthionine Adenosyltransferase and S-adenosylmethionine in Liver Health and Disease: Shelly C. Lu and Jose M. Mato; Acetone Metabolism in the Liver: Med. Habil. Miklos Peter Kalapos; Oxidative Stress and Liver Fibrosis: From Liver Injury to Modulation of Cell Signalling and Response: Elena Zamara et al.; Role of Nitric Oxide in Liver Disorders: Pablo Muriel; Renin-Angiotensin System in Liver Fibrosis: Hitoshi Yoshiji et al.; * Section II: Immunological Basis of Liver Injury; Cell and Molecular Mechanisms in the Development of Chronic Liver Inflammation: Simon C. Afford and Patricia F. Lalor; Role of Activated Macrophages in Liver Disease: Ion Deaciuc and Craig J. McClain; Investigations into Basis for Immune Recognition of Cellular Targets in Primary Biliary Cirrhosis: Ruth Joplin; Cross Talk of Hepatocytes and Nonparenchymal Liver Cells in Physiology and Pathology: Monoxides and Eicosanoids: Zbigniew Kmiec; Activity of Cytokines in Chronic HCV Infection and Influence of Antiviral Drugs: Tadeusz Wojciech Lapinski; Role of Chemokines in Liver Pathophysiology: Fabio Marra. Volume 2: Clinical Liver Diseases: Pathophysiology, Diagnostic and Therapeutic Insights; * Section III: Clinical Liver Disease Pathophysiology; Nonalcoholic Fatty Liver Diseases: Clinical and Pathophysiological Features: Frank A. Anania; Genetic Basis of Hepatocellular Cancer: Sigal Tal-Kremer et al.; Haemochromatosis: Recent Advances: AJM Davis and WM Rosenberg; Pathophysiology of Cirrhotic Ascites: Recent Advances: George Therapondos and Florence Wong; Cryptogenic Hepatitis: Isabelle Chemin; HIV-1 and the Liver: Sandro Vento and Francesca Cainelli; Cell Death by Necrosis: Mechanisms and Interception in the Liver: Shakir Ali; Fulminant Hepatic Failure: Etiology, Pathogenesis, and Treatment: Eran Elinav and Rafael Bruckl; * Section IV: Therapeutic and Diagnostic Insights; Advances in Biology and Therapy of Hepatitis B Virus Infection: Frank Tacke et al.; Hepatitis C Virus: Molecular Virology and Therapeutic Targets: Andrew Macdonald and Mark Harris; Drug Targeting to Hepatic Stellate Cells: A New Strategy to Treat Liver Fibrosis: Leonie Beljaars et al.; Developing Therapeutic Strategies for Hepatic Fibrosis: Ichiro Shimizu; Liver Disease, Oxidative Stress and Ursodeoxycholic Acid: Predrag Ljubuncic and Arieh Bomzon; Plasma TGF-b as a Diagnostic and Prognostic Marker: M. Antoine et al.; Hepatocytes as the Gold Standard for Predicting in-vivo Hepatotoxicity of Xenobiotics Using Accelerated Cytotoxicity Mechanism Screening Techniques: Peter J.O'Brien et al.